<!DOCTYPE html><html lang="en"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1"/><link rel="preload" href="/drug-cards/_next/static/media/a34f9d1faa5f3315-s.p.woff2" as="font" crossorigin="" type="font/woff2"/><link rel="stylesheet" href="/drug-cards/_next/static/css/c342ecc7a80fcd6f.css" crossorigin="" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" href="/drug-cards/_next/static/chunks/webpack-70d613c349ab756b.js" crossorigin=""/><script src="/drug-cards/_next/static/chunks/fd9d1056-973f819f03e866e6.js" async="" crossorigin=""></script><script src="/drug-cards/_next/static/chunks/938-7b7871f5b4927dea.js" async="" crossorigin=""></script><script src="/drug-cards/_next/static/chunks/main-app-ceb2f472185f781f.js" async="" crossorigin=""></script><script src="/drug-cards/_next/static/chunks/287-75c095874c725287.js" async=""></script><script src="/drug-cards/_next/static/chunks/app/page-c44d1834d56e2fa9.js" async=""></script><title>Drug Cards Dashboard</title><meta name="description" content="2025 Drugs to Watch - Comprehensive Pipeline"/><link rel="icon" href="/drug-cards/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="next-size-adjust"/><script src="/drug-cards/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js" crossorigin="" noModule=""></script></head><body class="__className_43b4f6"><main><div class="min-h-screen bg-gradient-to-br from-indigo-50 via-white to-blue-50 p-8"><div class="max-w-[95%] mx-auto space-y-12"><div class="text-center space-y-2"><h1 class="text-5xl font-bold bg-gradient-to-r from-indigo-600 to-blue-700 bg-clip-text text-transparent leading-tight pb-2">2025 Drugs to Watch</h1><p class="text-xl text-gray-600 font-medium">Comprehensive Analysis &amp; Market Outlook</p></div><div class="relative"><button class="absolute left-0 top-1/2 -translate-y-1/2 -translate-x-4 z-10 p-3 rounded-full bg-white shadow-lg hover:bg-gray-50 transition-all duration-200 hover:scale-110 focus:outline-none group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-chevron-left w-6 h-6 text-gray-600 group-hover:text-indigo-600"><path d="m15 18-6-6 6-6"></path></svg></button><div class="flex overflow-x-auto gap-8 py-8 px-8 hide-scrollbar snap-x snap-mandatory" style="scrollbar-width:none;-ms-overflow-style:none"><div class="snap-center flex-shrink-0"><div class="text-gray-950 shadow dark:border-gray-800 dark:bg-gray-800 dark:text-gray-50 relative min-w-[400px] overflow-hidden transform transition-all duration-300 hover:scale-105 hover:shadow-2xl bg-white rounded-xl border border-gray-200"><div class="bg-gradient-to-r from-indigo-600 to-blue-700 p-8 text-white"><div class="space-y-2"><h3 class="text-3xl font-bold tracking-tight">AWIQLI</h3><p class="text-base text-indigo-100 font-medium">Novo Nordisk</p></div></div><div class="p-8 space-y-8 bg-gradient-to-b from-white to-gray-50"><div class="grid grid-cols-2 gap-8"><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-calendar w-5 h-5 mr-2 text-indigo-600"><rect width="18" height="18" x="3" y="4" rx="2" ry="2"></rect><line x1="16" x2="16" y1="2" y2="6"></line><line x1="8" x2="8" y1="2" y2="6"></line><line x1="3" x2="21" y1="10" y2="10"></line></svg><span class="text-sm font-semibold">Expected Launch</span></div><p class="font-bold text-lg text-gray-900 ml-7">2024-2025</p></div><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-dollar-sign w-5 h-5 mr-2 text-indigo-600"><line x1="12" x2="12" y1="2" y2="22"></line><path d="M17 5H9.5a3.5 3.5 0 0 0 0 7h5a3.5 3.5 0 0 1 0 7H6"></path></svg><span class="text-sm font-semibold">2030 Sales</span></div><p class="font-bold text-lg text-gray-900 ml-7">$<!-- -->4.7<!-- -->B</p></div></div><div class="space-y-6"><div><h4 class="font-bold text-lg text-gray-900 mb-2">Indication</h4><p class="text-base text-gray-700 leading-relaxed">Type 1 and Type 2 Diabetes Mellitus</p></div><div><h4 class="font-bold text-lg text-gray-900 mb-2">Mechanism of Action</h4><p class="text-base text-gray-700 leading-relaxed">Long-acting basal insulin analog</p></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Success Probability</h4><div class="space-y-2"><div class="flex justify-between items-center"><span class="text-base text-gray-700 font-medium">United States</span><span class="font-bold text-gray-900">95<!-- -->%</span></div><div class="h-3 bg-gray-100 rounded-full overflow-hidden"><div class="h-full rounded-full transition-all duration-500 bg-green-600" style="width:95%"></div></div></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Key Features</h4><ul class="space-y-3"><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">First once-weekly insulin</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Mobile app for dose optimization</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Similar hypoglycemia rates to daily insulin</span></li></ul></div></div></div></div><div class="snap-center flex-shrink-0"><div class="text-gray-950 shadow dark:border-gray-800 dark:bg-gray-800 dark:text-gray-50 relative min-w-[400px] overflow-hidden transform transition-all duration-300 hover:scale-105 hover:shadow-2xl bg-white rounded-xl border border-gray-200"><div class="bg-gradient-to-r from-indigo-600 to-blue-700 p-8 text-white"><div class="space-y-2"><h3 class="text-3xl font-bold tracking-tight">CagriSema</h3><p class="text-base text-indigo-100 font-medium">Novo Nordisk</p></div></div><div class="p-8 space-y-8 bg-gradient-to-b from-white to-gray-50"><div class="grid grid-cols-2 gap-8"><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-calendar w-5 h-5 mr-2 text-indigo-600"><rect width="18" height="18" x="3" y="4" rx="2" ry="2"></rect><line x1="16" x2="16" y1="2" y2="6"></line><line x1="8" x2="8" y1="2" y2="6"></line><line x1="3" x2="21" y1="10" y2="10"></line></svg><span class="text-sm font-semibold">Expected Launch</span></div><p class="font-bold text-lg text-gray-900 ml-7">2026-2027</p></div><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-dollar-sign w-5 h-5 mr-2 text-indigo-600"><line x1="12" x2="12" y1="2" y2="22"></line><path d="M17 5H9.5a3.5 3.5 0 0 0 0 7h5a3.5 3.5 0 0 1 0 7H6"></path></svg><span class="text-sm font-semibold">2030 Sales</span></div><p class="font-bold text-lg text-gray-900 ml-7">$<!-- -->8.3<!-- -->B</p></div></div><div class="space-y-6"><div><h4 class="font-bold text-lg text-gray-900 mb-2">Indication</h4><p class="text-base text-gray-700 leading-relaxed">Obesity and Type 2 Diabetes</p></div><div><h4 class="font-bold text-lg text-gray-900 mb-2">Mechanism of Action</h4><p class="text-base text-gray-700 leading-relaxed">GLP-1 RA + long-acting amylin analog</p></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Success Probability</h4><div class="space-y-2"><div class="flex justify-between items-center"><span class="text-base text-gray-700 font-medium">European Union</span><span class="font-bold text-gray-900">71<!-- -->%</span></div><div class="h-3 bg-gray-100 rounded-full overflow-hidden"><div class="h-full rounded-full transition-all duration-500 bg-yellow-500" style="width:71%"></div></div></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Key Features</h4><ul class="space-y-3"><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">First FDC amylin and GLP-1 RA</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Superior weight loss vs. existing options</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Potential cardiovascular benefits</span></li></ul></div></div></div></div><div class="snap-center flex-shrink-0"><div class="text-gray-950 shadow dark:border-gray-800 dark:bg-gray-800 dark:text-gray-50 relative min-w-[400px] overflow-hidden transform transition-all duration-300 hover:scale-105 hover:shadow-2xl bg-white rounded-xl border border-gray-200"><div class="bg-gradient-to-r from-indigo-600 to-blue-700 p-8 text-white"><div class="space-y-2"><h3 class="text-3xl font-bold tracking-tight">COBENFY</h3><p class="text-base text-indigo-100 font-medium">Bristol Myers Squibb</p></div></div><div class="p-8 space-y-8 bg-gradient-to-b from-white to-gray-50"><div class="grid grid-cols-2 gap-8"><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-calendar w-5 h-5 mr-2 text-indigo-600"><rect width="18" height="18" x="3" y="4" rx="2" ry="2"></rect><line x1="16" x2="16" y1="2" y2="6"></line><line x1="8" x2="8" y1="2" y2="6"></line><line x1="3" x2="21" y1="10" y2="10"></line></svg><span class="text-sm font-semibold">Expected Launch</span></div><p class="font-bold text-lg text-gray-900 ml-7">2024</p></div><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-dollar-sign w-5 h-5 mr-2 text-indigo-600"><line x1="12" x2="12" y1="2" y2="22"></line><path d="M17 5H9.5a3.5 3.5 0 0 0 0 7h5a3.5 3.5 0 0 1 0 7H6"></path></svg><span class="text-sm font-semibold">2030 Sales</span></div><p class="font-bold text-lg text-gray-900 ml-7">$<!-- -->1.6<!-- -->B</p></div></div><div class="space-y-6"><div><h4 class="font-bold text-lg text-gray-900 mb-2">Indication</h4><p class="text-base text-gray-700 leading-relaxed">Schizophrenia</p></div><div><h4 class="font-bold text-lg text-gray-900 mb-2">Mechanism of Action</h4><p class="text-base text-gray-700 leading-relaxed">Dual M1/M4 muscarinic receptor agonist</p></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Success Probability</h4><div class="space-y-2"><div class="flex justify-between items-center"><span class="text-base text-gray-700 font-medium">European Union</span><span class="font-bold text-gray-900">21<!-- -->%</span></div><div class="h-3 bg-gray-100 rounded-full overflow-hidden"><div class="h-full rounded-full transition-all duration-500 bg-red-500" style="width:21%"></div></div></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Key Features</h4><ul class="space-y-3"><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">First novel MOA in 30+ years</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Improved tolerability profile</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Potential for earlier line use</span></li></ul></div></div></div></div><div class="snap-center flex-shrink-0"><div class="text-gray-950 shadow dark:border-gray-800 dark:bg-gray-800 dark:text-gray-50 relative min-w-[400px] overflow-hidden transform transition-all duration-300 hover:scale-105 hover:shadow-2xl bg-white rounded-xl border border-gray-200"><div class="bg-gradient-to-r from-indigo-600 to-blue-700 p-8 text-white"><div class="space-y-2"><h3 class="text-3xl font-bold tracking-tight">EBGLYSS</h3><p class="text-base text-indigo-100 font-medium">Eli Lilly &amp; Co</p></div></div><div class="p-8 space-y-8 bg-gradient-to-b from-white to-gray-50"><div class="grid grid-cols-2 gap-8"><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-calendar w-5 h-5 mr-2 text-indigo-600"><rect width="18" height="18" x="3" y="4" rx="2" ry="2"></rect><line x1="16" x2="16" y1="2" y2="6"></line><line x1="8" x2="8" y1="2" y2="6"></line><line x1="3" x2="21" y1="10" y2="10"></line></svg><span class="text-sm font-semibold">Expected Launch</span></div><p class="font-bold text-lg text-gray-900 ml-7">2024</p></div><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-dollar-sign w-5 h-5 mr-2 text-indigo-600"><line x1="12" x2="12" y1="2" y2="22"></line><path d="M17 5H9.5a3.5 3.5 0 0 0 0 7h5a3.5 3.5 0 0 1 0 7H6"></path></svg><span class="text-sm font-semibold">2030 Sales</span></div><p class="font-bold text-lg text-gray-900 ml-7">$<!-- -->6<!-- -->B</p></div></div><div class="space-y-6"><div><h4 class="font-bold text-lg text-gray-900 mb-2">Indication</h4><p class="text-base text-gray-700 leading-relaxed">Atopic Dermatitis</p></div><div><h4 class="font-bold text-lg text-gray-900 mb-2">Mechanism of Action</h4><p class="text-base text-gray-700 leading-relaxed">IL-13-targeting monoclonal antibody</p></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Success Probability</h4><div class="space-y-2"><div class="flex justify-between items-center"><span class="text-base text-gray-700 font-medium">Mainland China</span><span class="font-bold text-gray-900">56<!-- -->%</span></div><div class="h-3 bg-gray-100 rounded-full overflow-hidden"><div class="h-full rounded-full transition-all duration-500 bg-red-500" style="width:56%"></div></div></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Key Features</h4><ul class="space-y-3"><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Less frequent dosing than competitors</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Strong efficacy profile</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Favorable safety data</span></li></ul></div></div></div></div><div class="snap-center flex-shrink-0"><div class="text-gray-950 shadow dark:border-gray-800 dark:bg-gray-800 dark:text-gray-50 relative min-w-[400px] overflow-hidden transform transition-all duration-300 hover:scale-105 hover:shadow-2xl bg-white rounded-xl border border-gray-200"><div class="bg-gradient-to-r from-indigo-600 to-blue-700 p-8 text-white"><div class="space-y-2"><h3 class="text-3xl font-bold tracking-tight">Fitusiran</h3><p class="text-base text-indigo-100 font-medium">Alnylam/Sanofi</p></div></div><div class="p-8 space-y-8 bg-gradient-to-b from-white to-gray-50"><div class="grid grid-cols-2 gap-8"><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-calendar w-5 h-5 mr-2 text-indigo-600"><rect width="18" height="18" x="3" y="4" rx="2" ry="2"></rect><line x1="16" x2="16" y1="2" y2="6"></line><line x1="8" x2="8" y1="2" y2="6"></line><line x1="3" x2="21" y1="10" y2="10"></line></svg><span class="text-sm font-semibold">Expected Launch</span></div><p class="font-bold text-lg text-gray-900 ml-7">2025</p></div><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-dollar-sign w-5 h-5 mr-2 text-indigo-600"><line x1="12" x2="12" y1="2" y2="22"></line><path d="M17 5H9.5a3.5 3.5 0 0 0 0 7h5a3.5 3.5 0 0 1 0 7H6"></path></svg><span class="text-sm font-semibold">2030 Sales</span></div><p class="font-bold text-lg text-gray-900 ml-7">$<!-- -->1<!-- -->B</p></div></div><div class="space-y-6"><div><h4 class="font-bold text-lg text-gray-900 mb-2">Indication</h4><p class="text-base text-gray-700 leading-relaxed">Hemophilia A and B</p></div><div><h4 class="font-bold text-lg text-gray-900 mb-2">Mechanism of Action</h4><p class="text-base text-gray-700 leading-relaxed">Antithrombin-targeting siRNA</p></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Success Probability</h4><div class="space-y-2"><div class="flex justify-between items-center"><span class="text-base text-gray-700 font-medium">United States</span><span class="font-bold text-gray-900">95<!-- -->%</span></div><div class="h-3 bg-gray-100 rounded-full overflow-hidden"><div class="h-full rounded-full transition-all duration-500 bg-green-600" style="width:95%"></div></div></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Key Features</h4><ul class="space-y-3"><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Monthly/bimonthly dosing</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Effective regardless of inhibitor status</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Reduced treatment burden</span></li></ul></div></div></div></div><div class="snap-center flex-shrink-0"><div class="text-gray-950 shadow dark:border-gray-800 dark:bg-gray-800 dark:text-gray-50 relative min-w-[400px] overflow-hidden transform transition-all duration-300 hover:scale-105 hover:shadow-2xl bg-white rounded-xl border border-gray-200"><div class="bg-gradient-to-r from-indigo-600 to-blue-700 p-8 text-white"><div class="space-y-2"><h3 class="text-3xl font-bold tracking-tight">GSK-3536819</h3><p class="text-base text-indigo-100 font-medium">GSK</p></div></div><div class="p-8 space-y-8 bg-gradient-to-b from-white to-gray-50"><div class="grid grid-cols-2 gap-8"><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-calendar w-5 h-5 mr-2 text-indigo-600"><rect width="18" height="18" x="3" y="4" rx="2" ry="2"></rect><line x1="16" x2="16" y1="2" y2="6"></line><line x1="8" x2="8" y1="2" y2="6"></line><line x1="3" x2="21" y1="10" y2="10"></line></svg><span class="text-sm font-semibold">Expected Launch</span></div><p class="font-bold text-lg text-gray-900 ml-7">2025</p></div><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-dollar-sign w-5 h-5 mr-2 text-indigo-600"><line x1="12" x2="12" y1="2" y2="22"></line><path d="M17 5H9.5a3.5 3.5 0 0 0 0 7h5a3.5 3.5 0 0 1 0 7H6"></path></svg><span class="text-sm font-semibold">2030 Sales</span></div><p class="font-bold text-lg text-gray-900 ml-7">$<!-- -->0.91<!-- -->B</p></div></div><div class="space-y-6"><div><h4 class="font-bold text-lg text-gray-900 mb-2">Indication</h4><p class="text-base text-gray-700 leading-relaxed">Meningococcal Disease</p></div><div><h4 class="font-bold text-lg text-gray-900 mb-2">Mechanism of Action</h4><p class="text-base text-gray-700 leading-relaxed">Pentavalent vaccine targeting N. meningitidis</p></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Success Probability</h4><div class="space-y-2"><div class="flex justify-between items-center"><span class="text-base text-gray-700 font-medium">European Union</span><span class="font-bold text-gray-900">90<!-- -->%</span></div><div class="h-3 bg-gray-100 rounded-full overflow-hidden"><div class="h-full rounded-full transition-all duration-500 bg-green-600" style="width:90%"></div></div></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Key Features</h4><ul class="space-y-3"><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">5-in-1 vaccine targeting major strains</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Reduced number of injections</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Potential for broader population coverage</span></li></ul></div></div></div></div><div class="snap-center flex-shrink-0"><div class="text-gray-950 shadow dark:border-gray-800 dark:bg-gray-800 dark:text-gray-50 relative min-w-[400px] overflow-hidden transform transition-all duration-300 hover:scale-105 hover:shadow-2xl bg-white rounded-xl border border-gray-200"><div class="bg-gradient-to-r from-indigo-600 to-blue-700 p-8 text-white"><div class="space-y-2"><h3 class="text-3xl font-bold tracking-tight">IMDELLTRA</h3><p class="text-base text-indigo-100 font-medium">Amgen</p></div></div><div class="p-8 space-y-8 bg-gradient-to-b from-white to-gray-50"><div class="grid grid-cols-2 gap-8"><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-calendar w-5 h-5 mr-2 text-indigo-600"><rect width="18" height="18" x="3" y="4" rx="2" ry="2"></rect><line x1="16" x2="16" y1="2" y2="6"></line><line x1="8" x2="8" y1="2" y2="6"></line><line x1="3" x2="21" y1="10" y2="10"></line></svg><span class="text-sm font-semibold">Expected Launch</span></div><p class="font-bold text-lg text-gray-900 ml-7">2024</p></div><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-dollar-sign w-5 h-5 mr-2 text-indigo-600"><line x1="12" x2="12" y1="2" y2="22"></line><path d="M17 5H9.5a3.5 3.5 0 0 0 0 7h5a3.5 3.5 0 0 1 0 7H6"></path></svg><span class="text-sm font-semibold">2030 Sales</span></div><p class="font-bold text-lg text-gray-900 ml-7">$<!-- -->2.1<!-- -->B</p></div></div><div class="space-y-6"><div><h4 class="font-bold text-lg text-gray-900 mb-2">Indication</h4><p class="text-base text-gray-700 leading-relaxed">Small-cell Lung Cancer</p></div><div><h4 class="font-bold text-lg text-gray-900 mb-2">Mechanism of Action</h4><p class="text-base text-gray-700 leading-relaxed">DLL3 × CD3-targeting BiTE molecule</p></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Success Probability</h4><div class="space-y-2"><div class="flex justify-between items-center"><span class="text-base text-gray-700 font-medium">European Union</span><span class="font-bold text-gray-900">79<!-- -->%</span></div><div class="h-3 bg-gray-100 rounded-full overflow-hidden"><div class="h-full rounded-full transition-all duration-500 bg-yellow-500" style="width:79%"></div></div></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Key Features</h4><ul class="space-y-3"><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">First-in-class DLL3 × CD3 BiTE</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Impressive efficacy in SCLC</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Potential for multiple indications</span></li></ul></div></div></div></div><div class="snap-center flex-shrink-0"><div class="text-gray-950 shadow dark:border-gray-800 dark:bg-gray-800 dark:text-gray-50 relative min-w-[400px] overflow-hidden transform transition-all duration-300 hover:scale-105 hover:shadow-2xl bg-white rounded-xl border border-gray-200"><div class="bg-gradient-to-r from-indigo-600 to-blue-700 p-8 text-white"><div class="space-y-2"><h3 class="text-3xl font-bold tracking-tight">mRESVIA</h3><p class="text-base text-indigo-100 font-medium">Moderna</p></div></div><div class="p-8 space-y-8 bg-gradient-to-b from-white to-gray-50"><div class="grid grid-cols-2 gap-8"><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-calendar w-5 h-5 mr-2 text-indigo-600"><rect width="18" height="18" x="3" y="4" rx="2" ry="2"></rect><line x1="16" x2="16" y1="2" y2="6"></line><line x1="8" x2="8" y1="2" y2="6"></line><line x1="3" x2="21" y1="10" y2="10"></line></svg><span class="text-sm font-semibold">Expected Launch</span></div><p class="font-bold text-lg text-gray-900 ml-7">2024</p></div><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-dollar-sign w-5 h-5 mr-2 text-indigo-600"><line x1="12" x2="12" y1="2" y2="22"></line><path d="M17 5H9.5a3.5 3.5 0 0 0 0 7h5a3.5 3.5 0 0 1 0 7H6"></path></svg><span class="text-sm font-semibold">2030 Sales</span></div><p class="font-bold text-lg text-gray-900 ml-7">$<!-- -->1.4<!-- -->B</p></div></div><div class="space-y-6"><div><h4 class="font-bold text-lg text-gray-900 mb-2">Indication</h4><p class="text-base text-gray-700 leading-relaxed">RSV</p></div><div><h4 class="font-bold text-lg text-gray-900 mb-2">Mechanism of Action</h4><p class="text-base text-gray-700 leading-relaxed">mRNA vaccine</p></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Success Probability</h4><div class="space-y-2"><div class="flex justify-between items-center"><span class="text-base text-gray-700 font-medium">Japan</span><span class="font-bold text-gray-900">90<!-- -->%</span></div><div class="h-3 bg-gray-100 rounded-full overflow-hidden"><div class="h-full rounded-full transition-all duration-500 bg-green-600" style="width:90%"></div></div></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Key Features</h4><ul class="space-y-3"><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">First mRNA-based RSV vaccine</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Single-dose administration</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Strong efficacy profile</span></li></ul></div></div></div></div><div class="snap-center flex-shrink-0"><div class="text-gray-950 shadow dark:border-gray-800 dark:bg-gray-800 dark:text-gray-50 relative min-w-[400px] overflow-hidden transform transition-all duration-300 hover:scale-105 hover:shadow-2xl bg-white rounded-xl border border-gray-200"><div class="bg-gradient-to-r from-indigo-600 to-blue-700 p-8 text-white"><div class="space-y-2"><h3 class="text-3xl font-bold tracking-tight">SEL-212</h3><p class="text-base text-indigo-100 font-medium">Sobi</p></div></div><div class="p-8 space-y-8 bg-gradient-to-b from-white to-gray-50"><div class="grid grid-cols-2 gap-8"><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-calendar w-5 h-5 mr-2 text-indigo-600"><rect width="18" height="18" x="3" y="4" rx="2" ry="2"></rect><line x1="16" x2="16" y1="2" y2="6"></line><line x1="8" x2="8" y1="2" y2="6"></line><line x1="3" x2="21" y1="10" y2="10"></line></svg><span class="text-sm font-semibold">Expected Launch</span></div><p class="font-bold text-lg text-gray-900 ml-7">2025</p></div><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-dollar-sign w-5 h-5 mr-2 text-indigo-600"><line x1="12" x2="12" y1="2" y2="22"></line><path d="M17 5H9.5a3.5 3.5 0 0 0 0 7h5a3.5 3.5 0 0 1 0 7H6"></path></svg><span class="text-sm font-semibold">2030 Sales</span></div><p class="font-bold text-lg text-gray-900 ml-7">$<!-- -->1.7<!-- -->B</p></div></div><div class="space-y-6"><div><h4 class="font-bold text-lg text-gray-900 mb-2">Indication</h4><p class="text-base text-gray-700 leading-relaxed">Gout</p></div><div><h4 class="font-bold text-lg text-gray-900 mb-2">Mechanism of Action</h4><p class="text-base text-gray-700 leading-relaxed">ImmTOR + pegylated uricase</p></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Success Probability</h4><div class="space-y-2"><div class="flex justify-between items-center"><span class="text-base text-gray-700 font-medium">United States</span><span class="font-bold text-gray-900">95<!-- -->%</span></div><div class="h-3 bg-gray-100 rounded-full overflow-hidden"><div class="h-full rounded-full transition-all duration-500 bg-green-600" style="width:95%"></div></div></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Key Features</h4><ul class="space-y-3"><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Novel immune tolerance technology</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Monthly administration</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Improved immunogenicity profile</span></li></ul></div></div></div></div><div class="snap-center flex-shrink-0"><div class="text-gray-950 shadow dark:border-gray-800 dark:bg-gray-800 dark:text-gray-50 relative min-w-[400px] overflow-hidden transform transition-all duration-300 hover:scale-105 hover:shadow-2xl bg-white rounded-xl border border-gray-200"><div class="bg-gradient-to-r from-indigo-600 to-blue-700 p-8 text-white"><div class="space-y-2"><h3 class="text-3xl font-bold tracking-tight">Vepdegestrant</h3><p class="text-base text-indigo-100 font-medium">Arvinas/Pfizer</p></div></div><div class="p-8 space-y-8 bg-gradient-to-b from-white to-gray-50"><div class="grid grid-cols-2 gap-8"><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-calendar w-5 h-5 mr-2 text-indigo-600"><rect width="18" height="18" x="3" y="4" rx="2" ry="2"></rect><line x1="16" x2="16" y1="2" y2="6"></line><line x1="8" x2="8" y1="2" y2="6"></line><line x1="3" x2="21" y1="10" y2="10"></line></svg><span class="text-sm font-semibold">Expected Launch</span></div><p class="font-bold text-lg text-gray-900 ml-7">2025</p></div><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-dollar-sign w-5 h-5 mr-2 text-indigo-600"><line x1="12" x2="12" y1="2" y2="22"></line><path d="M17 5H9.5a3.5 3.5 0 0 0 0 7h5a3.5 3.5 0 0 1 0 7H6"></path></svg><span class="text-sm font-semibold">2030 Sales</span></div><p class="font-bold text-lg text-gray-900 ml-7">$<!-- -->1.19<!-- -->B</p></div></div><div class="space-y-6"><div><h4 class="font-bold text-lg text-gray-900 mb-2">Indication</h4><p class="text-base text-gray-700 leading-relaxed">Breast Cancer</p></div><div><h4 class="font-bold text-lg text-gray-900 mb-2">Mechanism of Action</h4><p class="text-base text-gray-700 leading-relaxed">ER PROTAC degrader</p></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Success Probability</h4><div class="space-y-2"><div class="flex justify-between items-center"><span class="text-base text-gray-700 font-medium">European Union</span><span class="font-bold text-gray-900">64<!-- -->%</span></div><div class="h-3 bg-gray-100 rounded-full overflow-hidden"><div class="h-full rounded-full transition-all duration-500 bg-red-500" style="width:64%"></div></div></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Key Features</h4><ul class="space-y-3"><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">First PROTAC protein degrader</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Novel approach to ER degradation</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Potential for combination therapy</span></li></ul></div></div></div></div><div class="snap-center flex-shrink-0"><div class="text-gray-950 shadow dark:border-gray-800 dark:bg-gray-800 dark:text-gray-50 relative min-w-[400px] overflow-hidden transform transition-all duration-300 hover:scale-105 hover:shadow-2xl bg-white rounded-xl border border-gray-200"><div class="bg-gradient-to-r from-indigo-600 to-blue-700 p-8 text-white"><div class="space-y-2"><h3 class="text-3xl font-bold tracking-tight">Zanzalintinib</h3><p class="text-base text-indigo-100 font-medium">Exelixis</p></div></div><div class="p-8 space-y-8 bg-gradient-to-b from-white to-gray-50"><div class="grid grid-cols-2 gap-8"><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-calendar w-5 h-5 mr-2 text-indigo-600"><rect width="18" height="18" x="3" y="4" rx="2" ry="2"></rect><line x1="16" x2="16" y1="2" y2="6"></line><line x1="8" x2="8" y1="2" y2="6"></line><line x1="3" x2="21" y1="10" y2="10"></line></svg><span class="text-sm font-semibold">Expected Launch</span></div><p class="font-bold text-lg text-gray-900 ml-7">2026</p></div><div><div class="flex items-center text-gray-700 mb-2"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-dollar-sign w-5 h-5 mr-2 text-indigo-600"><line x1="12" x2="12" y1="2" y2="22"></line><path d="M17 5H9.5a3.5 3.5 0 0 0 0 7h5a3.5 3.5 0 0 1 0 7H6"></path></svg><span class="text-sm font-semibold">2030 Sales</span></div><p class="font-bold text-lg text-gray-900 ml-7">$<!-- -->2.6<!-- -->B</p></div></div><div class="space-y-6"><div><h4 class="font-bold text-lg text-gray-900 mb-2">Indication</h4><p class="text-base text-gray-700 leading-relaxed">Multiple Cancers</p></div><div><h4 class="font-bold text-lg text-gray-900 mb-2">Mechanism of Action</h4><p class="text-base text-gray-700 leading-relaxed">Multi-targeted tyrosine kinase inhibitor</p></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Success Probability</h4><div class="space-y-2"><div class="flex justify-between items-center"><span class="text-base text-gray-700 font-medium">United States</span><span class="font-bold text-gray-900">43<!-- -->%</span></div><div class="h-3 bg-gray-100 rounded-full overflow-hidden"><div class="h-full rounded-full transition-all duration-500 bg-red-500" style="width:43%"></div></div></div></div><div class="space-y-4"><h4 class="font-bold text-lg text-gray-900">Key Features</h4><ul class="space-y-3"><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Third-generation TKI</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Multiple cancer indications</span></li><li class="flex items-start group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-up-right w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"><path d="M7 7h10v10"></path><path d="M7 17 17 7"></path></svg><span class="text-base text-gray-700">Improved pharmacokinetics</span></li></ul></div></div></div></div></div><button class="absolute right-0 top-1/2 -translate-y-1/2 translate-x-4 z-10 p-3 rounded-full bg-white shadow-lg hover:bg-gray-50 transition-all duration-200 hover:scale-110 focus:outline-none group"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-chevron-right w-6 h-6 text-gray-600 group-hover:text-indigo-600"><path d="m9 18 6-6-6-6"></path></svg></button></div></div></div></main><script src="/drug-cards/_next/static/chunks/webpack-70d613c349ab756b.js" crossorigin="" async=""></script><script>(self.__next_f=self.__next_f||[]).push([0]);self.__next_f.push([2,null])</script><script>self.__next_f.push([1,"1:HL[\"/drug-cards/_next/static/media/a34f9d1faa5f3315-s.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"type\":\"font/woff2\"}]\n2:HL[\"/drug-cards/_next/static/css/c342ecc7a80fcd6f.css\",\"style\",{\"crossOrigin\":\"\"}]\n0:\"$L3\"\n"])</script><script>self.__next_f.push([1,"4:I[7690,[],\"\"]\n6:I[5438,[\"287\",\"static/chunks/287-75c095874c725287.js\",\"931\",\"static/chunks/app/page-c44d1834d56e2fa9.js\"],\"\"]\n7:I[5613,[],\"\"]\n8:I[1778,[],\"\"]\na:I[8955,[],\"\"]\n"])</script><script>self.__next_f.push([1,"3:[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/drug-cards/_next/static/css/c342ecc7a80fcd6f.css\",\"precedence\":\"next\",\"crossOrigin\":\"\"}]],[\"$\",\"$L4\",null,{\"buildId\":\"m14DAAsbiGVHgK0HUZwAC\",\"assetPrefix\":\"/drug-cards\",\"initialCanonicalUrl\":\"/\",\"initialTree\":[\"\",{\"children\":[\"__PAGE__\",{}]},\"$undefined\",\"$undefined\",true],\"initialSeedData\":[\"\",{\"children\":[\"__PAGE__\",{},[\"$L5\",[\"$\",\"main\",null,{\"children\":[\"$\",\"$L6\",null,{}]}],null]]},[null,[\"$\",\"html\",null,{\"lang\":\"en\",\"children\":[\"$\",\"body\",null,{\"className\":\"__className_43b4f6\",\"children\":[\"$\",\"$L7\",null,{\"parallelRouterKey\":\"children\",\"segmentPath\":[\"children\"],\"loading\":\"$undefined\",\"loadingStyles\":\"$undefined\",\"loadingScripts\":\"$undefined\",\"hasLoading\":false,\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L8\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"title\",null,{\"children\":\"404: This page could not be found.\"}],[\"$\",\"div\",null,{\"style\":{\"fontFamily\":\"system-ui,\\\"Segoe UI\\\",Roboto,Helvetica,Arial,sans-serif,\\\"Apple Color Emoji\\\",\\\"Segoe UI Emoji\\\"\",\"height\":\"100vh\",\"textAlign\":\"center\",\"display\":\"flex\",\"flexDirection\":\"column\",\"alignItems\":\"center\",\"justifyContent\":\"center\"},\"children\":[\"$\",\"div\",null,{\"children\":[[\"$\",\"style\",null,{\"dangerouslySetInnerHTML\":{\"__html\":\"body{color:#000;background:#fff;margin:0}.next-error-h1{border-right:1px solid rgba(0,0,0,.3)}@media (prefers-color-scheme:dark){body{color:#fff;background:#000}.next-error-h1{border-right:1px solid rgba(255,255,255,.3)}}\"}}],[\"$\",\"h1\",null,{\"className\":\"next-error-h1\",\"style\":{\"display\":\"inline-block\",\"margin\":\"0 20px 0 0\",\"padding\":\"0 23px 0 0\",\"fontSize\":24,\"fontWeight\":500,\"verticalAlign\":\"top\",\"lineHeight\":\"49px\"},\"children\":\"404\"}],[\"$\",\"div\",null,{\"style\":{\"display\":\"inline-block\"},\"children\":[\"$\",\"h2\",null,{\"style\":{\"fontSize\":14,\"fontWeight\":400,\"lineHeight\":\"49px\",\"margin\":0},\"children\":\"This page could not be found.\"}]}]]}]}]],\"notFoundStyles\":[],\"styles\":null}]}]}],null]],\"initialHead\":[false,\"$L9\"],\"globalErrorComponent\":\"$a\"}]]\n"])</script><script>self.__next_f.push([1,"9:[[\"$\",\"meta\",\"0\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1\"}],[\"$\",\"meta\",\"1\",{\"charSet\":\"utf-8\"}],[\"$\",\"title\",\"2\",{\"children\":\"Drug Cards Dashboard\"}],[\"$\",\"meta\",\"3\",{\"name\":\"description\",\"content\":\"2025 Drugs to Watch - Comprehensive Pipeline\"}],[\"$\",\"link\",\"4\",{\"rel\":\"icon\",\"href\":\"/drug-cards/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"meta\",\"5\",{\"name\":\"next-size-adjust\"}]]\n5:null\n"])</script><script>self.__next_f.push([1,""])</script></body></html>